Tempest Therapeutics (TPST) Interest Coverage Ratio (2021 - 2025)

Tempest Therapeutics has disclosed Interest Coverage Ratio across 5 years of filings, most recently posting 173.17 for Q2 2025.

• In Q2 2025, Interest Coverage Ratio fell 572.31% year-over-year to 173.17; the TTM figure through Jun 2026 stood at 454.13 (down 719.87% YoY), while the FY2025 annual figure was 128.38, down 302.01% from the prior year.
• Interest Coverage Ratio came in at 173.17 for Q2 2025 at Tempest Therapeutics, down from 67.93 in the prior quarter.
• In the past five years, Interest Coverage Ratio ranged from a high of 17.67 in Q3 2023 to a low of 173.17 in Q2 2025.
• Average Interest Coverage Ratio over 5 years is 35.03, with a median of 22.12 recorded in 2023.
• Year-over-year, Interest Coverage Ratio advanced 23.08% in 2022 and sank 572.31% in 2025.
• Over 5 years, Interest Coverage Ratio stood at 21.71 in 2021, then climbed by 4.74% to 20.68 in 2022, then rose by 3.62% to 19.93 in 2023, then sank by 182.72% to 56.35 in 2024, then slumped by 207.33% to 173.17 in 2025.
• Per Business Quant data, the three most recent Interest Coverage Ratio figures were 173.17 in Q2 2025, 67.93 in Q1 2025, and 56.35 in Q4 2024.